Clinical Circulating Tumor DNA Testing for Precision Oncology
Cancer Research and Treatment · 15.04.2023 · 55 (2) · 351-366
DOI: 10.4143/crt.2022.1026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, erschienen am 15.04.2023. Verfasst von Hyunji Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Neoplasms, Circulating Tumor DNA. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 mL of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours. Obtaining reliable results from ctDNA requires the application and approval of standardized clinical validation guidelines; however, the status of numerous ctDNA tests currently varies. The clinical use of ctDNA testing should be carefully considered based on the test’s specific needs and characteristics. Here we provide the different characteristics of ctDNA tests and information regarding their validation and approval status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Zitieren
APA
Kim, H., & Park, K. U. (2023). Clinical Circulating Tumor DNA Testing for Precision Oncology. Cancer Research and Treatment, 55(2), 351-366. https://doi.org/10.4143/crt.2022.1026
Vancouver
Kim H, Park KU. Clinical Circulating Tumor DNA Testing for Precision Oncology. Cancer Research and Treatment. 2023;55(2):351-366. doi:10.4143/crt.2022.1026
BibTeX
@article{Kim2023,
author = {Kim, Hyunji and Park, Kyoung Un},
title = {Clinical Circulating Tumor DNA Testing for Precision Oncology},
journal = {Cancer Research and Treatment},
year = {2023},
volume = {55},
number = {2},
pages = {351--366},
doi = {10.4143/crt.2022.1026}
}
EUVIMED